Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis — Andrea C. Tricco (2013) | RDL Network
Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis
Andrea C. Tricco, Huda Ashoor, Jesmin Antony, Joseph Beyene, A. A. Veroniki, Wanrudee Isaranuwatchai, A. Harrington, Charlotte Wilson, Sophia Tsouros, Charlene Soobiah, Catherine Yu, Brian Hutton, Jeffrey S. Hoch, Brenda R. Hemmelgarn, David Moher, Sumit R. Majumdar, Sharon E. Straus
Andrea C. Tricco, Jesmin Antony, Veroniki A Angeliki, Huda Ashoor, Brian Hutton, Brenda R. Hemmelgarn, David Moher, Yaron Finkelstein, Kevin Gough, Sharon E. Straus
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.